Logo image of SYKE

Sykes Enterprises (SYKE) Stock Fundamental Analysis

NASDAQ:SYKE - Nasdaq -

54  +0.02 (+0.04%)

After market: 54 0 (0%)

Fundamental Rating

3

SYKE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the IT Services industry. The financial health of SYKE is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SYKE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SYKE had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 4.87%
ROE 7.25%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 5.11%
PM (TTM) 3.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

There is no outstanding debt for SYKE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 5.21 indicates that SYKE is not in any danger for bankruptcy at the moment.
SYKE has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 5.21
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

SYKE has a Current Ratio of 2.03. This indicates that SYKE is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.03 indicates that SYKE has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.25% over the past year.
Measured over the past 5 years, SYKE shows a small growth in Earnings Per Share. The EPS has been growing by 7.67% on average per year.
SYKE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.37%.
Measured over the past years, SYKE shows a small growth in Revenue. The Revenue has been growing by 5.86% on average per year.
EPS 1Y (TTM)26.25%
EPS 3Y10.79%
EPS 5Y7.67%
EPS Q2Q%2.82%
Revenue 1Y (TTM)8.37%
Revenue growth 3Y2.55%
Revenue growth 5Y5.86%
Sales Q2Q%7.69%

3.2 Future

SYKE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.47% yearly.
Based on estimates for the next years, SYKE will show a small growth in Revenue. The Revenue will grow by 6.34% on average per year.
EPS Next Y14.94%
EPS Next 2Y12.25%
EPS Next 3Y11.44%
EPS Next 5Y8.47%
Revenue Next Year8.85%
Revenue Next 2Y6.73%
Revenue Next 3Y6.21%
Revenue Next 5Y6.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYKE Yearly Revenue VS EstimatesSYKE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
SYKE Yearly EPS VS EstimatesSYKE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

SYKE is valuated rather expensively with a Price/Earnings ratio of 17.82.
When comparing the Price/Earnings ratio of SYKE to the average of the S&P500 Index (29.62), we can say SYKE is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.76, which indicates a correct valuation of SYKE.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, SYKE is valued a bit cheaper.
Industry RankSector Rank
PE 17.82
Fwd PE 15.76
SYKE Price Earnings VS Forward Price EarningsSYKE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.42
SYKE Per share dataSYKE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.19
PEG (5Y)2.32
EPS Next 2Y12.25%
EPS Next 3Y11.44%

0

5. Dividend

5.1 Amount

SYKE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Sykes Enterprises

NASDAQ:SYKE (8/26/2021, 8:50:51 PM)

After market: 54 0 (0%)

54

+0.02 (+0.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners0.01%
Inst Owner Change0%
Ins Owners0.43%
Ins Owner Change0%
Market Cap2.15B
Analysts60
Price Target55.08 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.82
Fwd PE 15.76
P/S 1.2
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB N/A
EV/EBITDA 13.42
EPS(TTM)3.03
EY5.61%
EPS(NY)3.43
Fwd EY6.35%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS44.96
BVpS23.74
TBVpSN/A
PEG (NY)1.19
PEG (5Y)2.32
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 7.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.11%
PM (TTM) 3.83%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z 5.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.25%
EPS 3Y10.79%
EPS 5Y7.67%
EPS Q2Q%2.82%
EPS Next Y14.94%
EPS Next 2Y12.25%
EPS Next 3Y11.44%
EPS Next 5Y8.47%
Revenue 1Y (TTM)8.37%
Revenue growth 3Y2.55%
Revenue growth 5Y5.86%
Sales Q2Q%7.69%
Revenue Next Year8.85%
Revenue Next 2Y6.73%
Revenue Next 3Y6.21%
Revenue Next 5Y6.34%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A